SCHEMBL23952182

SCHEMBL23952182

CCn1nc(C(C)C)n2cc(C3CCN(C(=O)OC(C)(C)C)CC3)cc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.43
KDM4E B2RXH2 3/20 0.43
THRB P10828 1/20 0.43
DPP4 P27487 1/20 0.41
CNR1 P21554 1/20 0.40
ALDH1A1 P00352 5/20 0.39
MAPK1 P28482 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
RAB9A P51151 1/20 0.39
DDB1 Q16531 1/20 0.39
CRBN Q96SW2 1/20 0.39
TRPV3 Q8NET8 1/20 0.39
HPGD P15428 3/20 0.38
MEN1 O00255 2/20 0.38
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
USP2 O75604 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30380673 0.82 NLRP3 (0.62) MAPTCNR1ALDH1A1MAPK1L3MBTL1
SCHEMBL23952169 0.82 NLRP3 (0.62) MAPTCNR1ALDH1A1MAPK1L3MBTL1
SCHEMBL25818411 0.80 NLRP3 (0.44) MAPTKDM4ETHRBCNR1ALDH1A1
SCHEMBL25818404 0.80 NLRP3 (0.44) MAPTKDM4ETHRBCNR1ALDH1A1
SCHEMBL23952043 0.75 NLRP3 (0.46) THRBMEN1KMT2ANLRP3LMNA
SCHEMBL23952570 0.74 NLRP3 (0.42) KDM4ETHRBALDH1A1MAPK1L3MBTL1
SCHEMBL7606781 0.72 KDM4E (0.49) MAPTKDM4ETHRBDPP4CNR1
SCHEMBL5453963 0.70 KDM4E (0.49) MAPTKDM4ETHRBDPP4CNR1
SCHEMBL5445576 0.70 KDM4E (0.49) MAPTKDM4ETHRBDPP4ALDH1A1
SCHEMBL25815943 0.69 MAT2A (0.35) NLRP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021209539-A1 PYRROLO[1,2-D][1,2,4]TRIAZINE-2-YL-ACETAMIDES AS INHIBITORS OF THE NLRP3 INFLAMMASOME PATHWAY JANSSEN PHARMACEUTICA NV (BE) 2021-10-21 WO disclosed